Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous CarcinomaFlurina A.M. Saner, Jennifer M. Koziak, Kazuaki Takahashi et al.|Clinical Cancer Research|2024Cited by 14
Concurrent RB1 loss and <i>BRCA</i> -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinomaFlurina A.M. Saner, Jennifer M. Koziak, Kazuaki Takahashi et al.|medRxiv|2023Cited by 5
Current Practices And Barriers In HRD And BRCA Testing For Ovarian Cancer: Preliminary Findings From The European Network Of Young Gynaecologic Oncologists (ENYGO) Cross-Sectional StudyHoussein El-Hajj, Tibor A. Zwimpfer, Andrea Rosati et al.|International Journal of Gynecological Cancer|2025Cited by 1
Global trends and determinants of HRD and BRCA testing in ovarian cancer management: a cross-sectional study from the european network of young gynaecologic oncologists (ENYGO)Tibor A. Zwimpfer, Stamatios Petousis, Houssein El Hajj et al.|International Journal of Gynecological Cancer|2026Cited by 0